Uncategorized

Large study of Novo, Lilly weight loss drugs shows decrease in risk of Alzheimer’s – FiercePharma

Posted on Author Tim Hodges Comments Off on Large study of Novo, Lilly weight loss drugs shows decrease in risk of Alzheimer’s – FiercePharma
  1. Large study of Novo, Lilly weight loss drugs shows decrease in risk of Alzheimer’s  FiercePharma
  2. Obesity drugs: huge study identifies new health risks  Nature.com
  3. Weight-loss jabs linked to reduced risk of 42 conditions including dementia  The Guardian
  4. Popular GLP-1 medications may have health benefits that extend beyond weight loss and blood sugar control, a new study finds  CNN
  5. GLP-1 drugs like Ozempic and Wegovy lower the risk of 42 conditions  New Scientist